Early HCV clearance kinetic: analysis and comparison in non responders patients versus naive patients
Francesco Torre, A. Picciotto(University of Genoa), Avidan U. Neumann(University of Augsburg), Andrea Delfino, Giancarlo Icardi(Ospedale Policlinico San Martino), G. Percario, Angelo Rossini(Centro Universitário Barão de Mauá), Ilaria Comino, Rachel S. Levy‐Drummer
Cited by 1
Related Papers
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C
|Journal of Hepatology|2018|133
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia
|PLoS ONE|2020|128
Multiclass <scp>HCV</scp> resistance to direct‐acting antiviral failure in real‐life patients advocates for tailored second‐line therapies
|Liver International|2017|90
Iron reduction and sustained response to interferon-alpha therapy in patients with chronic hepatitis C: results of an Italian multicenter randomized study
|The American Journal of Gastroenterology|2002|80